Fulcrum Therapeutics, Inc. (FULC)

NASDAQ: FULC · IEX Real-Time Price · USD

8.00

-0.12 (-1.48%)

At close: Jul 19, 2024, 12:00 AM

7.89

-0.11 (-1.38%)

Pre-market: Jul 20, 2024, 9:29 AM EDT

Fulcrum Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	Current	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	497	417	379	717	322	388
Market Cap Growth	232.17%	10.13%	-47.17%	123.05%	-17.20%	-
Enterprise Value	293	191	188	498	208	291
PE Ratio	-	-4.29	-3.45	-8.87	-4.54	-4.32
PS Ratio	198.10	148.77	59.75	37.43	36.45	-
PB Ratio	2.33	1.77	1.91	3.39	3.38	4.46
P/FCF Ratio	-6.32	-4.56	-3.83	-8.94	-5.85	-9.63
P/OCF Ratio	-6.35	-4.59	-3.90	-9.14	-5.99	-9.84
EV/Sales Ratio	116.67	68.03	29.70	25.99	23.53	-
EV/EBITDA Ratio	-3.91	-2.01	-1.75	-6.36	-3.03	-3.60
EV/EBIT Ratio	-3.82	-1.96	-1.71	-6.16	-2.93	-3.51
EV/FCF Ratio	-4.11	-2.09	-1.90	-6.21	-3.77	-7.20
Debt / Equity Ratio	0.05	0.05	0.07	-	-	-
Debt / EBITDA Ratio	-0.10	-0.11	-0.12	-	-	-
Debt / FCF Ratio	-0.11	-0.12	-0.14	-	-	-
Quick Ratio	20.06	17.39	12.21	11.61	4.36	8.06
Current Ratio	20.38	17.71	12.41	11.77	4.47	8.24
Asset Turnover	0.01	0.01	0.03	0.10	0.07	0
Return on Equity (ROE)	-40.60%	-36.60%	-57.10%	-47.50%	-72.10%	-764.90%
Return on Assets (ROA)	-37.20%	-33.60%	-49.40%	-41.20%	-55.40%	-91.50%
Return on Capital (ROIC)	-50.31%	-44.98%	-53.00%	-38.32%	-75.24%	-96.63%
Earnings Yield	-20.00%	-23.32%	-28.99%	-11.27%	-22.02%	-23.12%
FCF Yield	-18.60%	-21.92%	-26.13%	-11.18%	-17.10%	-10.39%
Buyback Yield / Dilution	-3.79%	-36.27%	-27.23%	-39.47%	-129.53%	-778.76%
Total Shareholder Return	-3.79%	-36.27%	-27.23%	-39.47%	-129.53%	-778.76%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).